COVID Vaccine Boosters: US Exploring Ways To Get Immunocompromised People An Extra Dose

Dosing is capped under emergency use authorizations, but studies show reduced antibody response following primary vaccination series in individuals with compromised immune systems; although BLA approval could allow for off-label prescribing, government officials are exploring other regulatory options for earlier access, including through a study.

Running away
ACIP members fear the growing issue of immunocompromised individuals pursuing an extra COVID-19 vaccine dose is 'running away from us.' • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers